Supreme Court Upholds IPR Standard Making Patent Invalidation Easier; Will Congress Reverse?
This article was originally published in The Pink Sheet Daily
Executive Summary
High court says inconsistent decisions by Patent Trial and Appeal Board and district court are okay; House and Senate bills would eliminate the broad standard but opposition by tech community could doom passage.
You may also be interested in...
US Supreme Court Seems Poised To Allow Patent Holders More Judicial Review Options
In case that could impact challenges of biopharma patents, Supreme Court questioned the consequences of not allowing courts to review PTAB institution decisions when petition may be time barred.
PTO Final Rule Dropping BRI Patent Claim Standard Offers No Deference To District Courts
Patent office may issue guidance on how PTAB will consider prior claim constructions; actions on other procedures may be coming in the 'near future.'
US Patent Reform Debate: Proposal To Eliminate BRI Patent Claim Standard Splits Stakeholders
BIO and PhRMA want PTAB to give district courts deference in construing patent claims; Rep. Lofgren is concerned PTAB will be prohibited from doing its own claim construction and Mylan cites potential for inconsistencies within PTO.